It is strongly advised that practitioners screen women for depression during and post-pregnancy, according to new OB/Gyn guidelines.
A new Committee Opinion issued by the American College of Obstetricians and Gynecologists advises clinicians to screen their patients for depression during their pregnancy and postpartum.
According to ACOG, 14% to 23% of pregnant women experience symptoms of depression during their pregnancy and 5% to 25% will experience postpartum depression. During pregnancy, maternal depression can lead to preeclampsia, preterm delivery, and low birth weight. Left untreated, maternal depression can negatively affect cognitive, neurologic, and motor skill development in the infant and the behavior and mental health of older children.
“With over 4 million births in the US every year, we’re talking about huge number of women with postpartum depression: between 200,000 to more than 1 million each year,” Gerald F. Joseph, MD, president of ACOG, said. “Unfortunately, we don’t have the data at this time to support a firm recommendation for universal antepartum and postpartum depression screening.
Noting that the perinatal period may be an appropriate time to screen because the mother is already seeing healthcare providers regularly, the Committee Opinion identifies a number of screening tools that take less than 10 minutes’ time and have specificity of 77% to 100%. The physician should decide which screening tools to incorporate, who should conduct the screening, and the frequency of screenings. Screenings are advised at least once during pregnancy and once postpartum. After physicians have screened patients, at-risk patients should be referred to an appropriate professional.
The committee opinion also recommended that medical practices consult payers before billing for depression screening.
Pinette MG, Wax JR. Obstet Gynecol. 2010; 115(1): 188-189.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More